Solenic Medical receives top votes from Shark Tank judges at Anterior Hip Foundation 2022 Innovation Symposium

MAY 13, 2022 – At the event, which featured judges from the senior management of various leading orthopedic companies. Ten innovative orthopedics companies presented at the Shark Tank, and of them, Solenic Medical received top votes from the judges in attendance, while Esy Solution received top votes from the general audience. 

MAY 13-14, 2022 – Be the first to see technologies currently in development in the Ortho Shark Tank session. .. >>Learn More

MARCH 16-18, 2022 – The must-attend medtech partnering & investment event of 2022 attended by leading medtech startup CEOs and the investors and deal-makers building the future .. >>Learn More

FEBRUARY 23-24, 2022 – The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors. .. >>Learn More

JUNE 6, 2021 – Solenic Medical participated in the 2021 Texas A&M New Ventures Competition (TNVC) held live at Texas A&M University after being held virtually in 2020. Twenty-one companies were invited to participate May 19-20 for… >>Full Article

MARCH 23, 2021 – What’s the commonality between VC funding and sheep? Both will help Solenic Medical on its path to treating prosthetic joint infection. The UT Southwestern-affiliated medical device startup, which has most of its workforce in DFW, is fresh off new raises and is looking to raise more as it gears up for renewed animal trials on its way to testing its tech in human patients. >>Full Article

MARCH 11, 2021 – The two-year anniversary point in any startup provides an opportunity to reflect on the surprises and unexpected turns in the road, many of which could not have been predicted. >>Full Article

SEPTEMBER 24, 2020 – Using alternating magnetic fields in technology created by UTSW researchers, Solenic Medical aims to provide a better way to treat prosthetic joint infections than the current standard of care. Recently, the startup received an FDA designation of a Breakthrough Device. >>Full Article

June 2, 2020 (Houston, Texas) – MassChallenge, a global network of zero-equity startup accelerators, today announced the 56 early-stage startups invited to join the 2020 MassChallenge Texas in Houston program. These startups have been rigorously vetted by a community of more than 500 expert judges and represent the top 11% of applications from around the world; the selected startups more than double the number of startups accepted to the program’s 2019 bootcamp. >>Full Article

April 16, 2020— The Texas A&M New Ventures Competition (TNVC) is hosting its annual competition completely online this year to protect competitors, judges and staff during the COVID-19 pandemic. Sixteen semifinalists and eight alternates for the 2020 competition will compete May 14 for hundreds of thousands in startup funds during online rounds of pitch competitions and judging. >>Full Article

HOUSTON, TX November 7, 2019—  Johnson & Johnson Innovation, JLABS  announced today at TMCx Demo Day 2019 that NERv Medical, PATH EX, and Solenic Medical have been selected as the award recipients in the JLABS @ TMC Breakthrough Medical Technologies QuickFire Challenge. The Challenge was designed to ignite innovation in health tech and provide the innovators with the best ideas resources to advance their science. The announcement was made by Allan Miranda, Head of JLABS Canada and Interim Head of JLABS @ TMC . >>Full Article

DALLASJune 19, 2019 — VIC Technology Venture Development, LLC (VIC) has announced that it has formed Solenic Medical, Inc. The company was established to develop and commercialize a method for treating prosthetic joint infection (PJI) based on technology exclusively licensed from University of Texas Southwestern Medical Center (UTSW). The patent-pending technology offers an approach for the eradication of biofilm from metallic implants. Advantages include non-invasive treatment of PJI through selective targeting of biofilms. >>Full Article

Comments are closed.